Agile Therapeutics Stock Forecast
Volatile ride for Agile Therapeutics stock price on Wednesday moving between $0.325 and $0.418
(Updated on Mar 27, 2024)
The Agile Therapeutics stock price gained 10.78% on the last trading day (Wednesday, 27th Mar 2024), rising from $0.334 to $0.370. During the last trading day the stock fluctuated 28.81% from a day low at $0.325 to a day high of $0.418. The price has fallen in 6 of the last 10 days and is down by -47.59% for this period. Volume fell on the last day by -1 million shares and in total, 461 thousand shares were bought and sold for approximately $170.72 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.310 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -69.41% during the next 3 months and, with a 90% probability hold a price between $0.0947 and $0.201 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
AGRX Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 10.78%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Agile Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.503 and $0.83. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Agile Therapeutics stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.334. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0935 between high and low, or 28.81%. For the last week the stock has had daily average volatility of 26.70%.
Agile Therapeutics is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (AGRX) For The Upcoming Trading Day Of Thursday 28th
For the upcoming trading day on Thursday, 28th we expect Agile Therapeutics to open at $0.371, and during the day (based on 14 day Average True Range), to move between $0.258 and $0.482, which gives a possible trading interval of +/-$0.112 (+/-30.25%) up or down from last closing price. If Agile Therapeutics takes out the full calculated possible swing range there will be an estimated 60.50% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $0.334, some $0.0360 (9.73%) from the current price of $0.370, our system finds the risk reward attractive.
Is Agile Therapeutics stock A Buy?
Agile Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -5.206 Strong Sell Candidate Unchanged
Predicted Opening Price for Agile Therapeutics of Thursday, March 28, 2024
Fair opening price March 28, 2024 | Current price |
---|---|
$0.371 ( 0.225%) | $0.370 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for AGRX
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.464 | 25.50 % | |
R2 | 0.429 | 15.84 % | ||
R1 | 0.407 | 9.88 % | ||
Current price: | 0.370 | |||
Support | S1 | 0.335 | -9.43 % | |
S2 | 0.313 | -15.39 % | ||
S3 | 0.277 | -25.05 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0 | . | |
R2 | 0 | . | ||
R1 | 0 | . | ||
Current price | 0.370 | |||
Support | S1 | 0.334 | -9.73% | |
S2 | 0 | . | ||
S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Agile Therapeutics Stock.